Trials / Conditions / Recurrent Aggressive Non-Hodgkin Lymphoma

Recurrent Aggressive Non-Hodgkin Lymphoma

4 registered clinical trials studyying Recurrent Aggressive Non-Hodgkin Lymphoma.

Status	Trial	Sponsor	Phase
Withdrawn	Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed A NCT04220008	M.D. Anderson Cancer Center	Phase 2
Completed	Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy NCT04409314	University of California, San Francisco	—
Completed	Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non NCT03003546	Mayo Clinic	Phase 1
Completed	Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin NCT03210662	M.D. Anderson Cancer Center	Phase 2